Chinese pharma Ribo Life Science has raised 470 million yuan ($66 million) in a Series C2 round, while IoT solutions developer QST Corporation has secured 350 million yuan ($49 million) in a Series B+ round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
